So record month in December, revenues from new clients to increase in 2nd half fy18. More clients signing up. Frustrating watching the dribble down sales , vastly underrated company.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
